Yehuda Handelsman to Biosimilar Pharmaceuticals
This is a "connection" page, showing publications Yehuda Handelsman has written about Biosimilar Pharmaceuticals.
Connection Strength
0.367
-
Immunogenicity, Efficacy, and Safety of Biosimilar Insulin Glargine (Gan & Lee Glargine) Compared With Originator Insulin Glargine (Lantus) in Patients With Type 1 Diabetes After 26?Weeks Treatment. Endocr Pract. 2024 Sep; 30(9):810-816.
Score: 0.225
-
AACE/ACE POSITION STATEMENT ON THE USE OF FOLLOW-ON BIOLOGICS AND BIOSIMILARS FOR ENDOCRINE DISEASES. Endocr Pract. 2017 Nov; 23(11):1345-1349.
Score: 0.142